SYNCOMFSyncom FormulationsSYNCOMF info
$0.27info-4.52%24h
Global rank15921
Market cap$249.35M
Change 7d-1.29%
YTD Performance44.63%
SP500 benchmarkOutperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    Syncom Formulations (SYNCOMF) Stock Overview

    Syncom Formulations (India) Limited manufactures, markets, and sells pharmaceutical formulation products in India. It operates through Manufacturing and Dealing in Pharmaceutical Drug & Formulations, Trading of Commodities, and Renting of Properties segments. The company offers antibiotics/antiinfectives, anthelmintics, antimalarial, cardiac, derma, gastro, gynae, opthal, ortho, and pediatrics formulations. It also offers anemia tablet and syrup, lycopene, minerals and vitamins capsules, products for eradication of vaginal pathogens, capsules for the treatment of menopause, herbal uterine tonic, syrup for the treatment lactation insufficiency, cough suppressants, liver tonic, medicine for burning urination, and nutritional supplements. In addition, the company engages in the trading of commodities and renting of properties. Further, it exports its products. The company offers its pharmaceutical formulations products in various dosage forms, such as tablets, capsules, liquids orals, liquid vials, ampoule injections and dry vial injections, dry syrups, ointments, inhalers, and herbals. Syncom Formulations (India) Limited was incorporated in 1988 and is based in Indore, India.

    SYNCOMF Stock Information

    Symbol
    SYNCOMF
    Address
    207, Saket NagarIndore, 452018India
    Founded
    -
    Trading hours
    -
    Website
    https://www.syncomformulations.com
    Country
    🇮🇳 India
    Phone Number
    91 73 1256 0458

    Syncom Formulations (SYNCOMF) Price Chart

    -
    Value:-

    Syncom Formulations Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $0.265261973083079
    N/A
    Market Cap
    $249.35M
    N/A
    Shares Outstanding
    940.00M
    N/A
    Employees
    555.00
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    © 2024 Topstocks.org